A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol
Clinical trial NCT03882762 · COMPLETED
Trial details
- NCT number
- NCT03882762
- Sponsor
- Tris Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-20
- Primary completion
- 2014-09-17
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.